Tazorac and Deep venous thrombosis - a phase IV clinical study of FDA data

Summary:

Deep venous thrombosis is reported as a side effect among people who take Tazorac (tazarotene), especially for people who are female, 50-59 old, have been taking the drug for 1 - 2 years also take Zyrtec, and have Psoriasis.

The phase IV clinical study analyzes which people have Deep venous thrombosis when taking Tazorac. It is created by eHealthMe based on reports of 1,001 people who have side effects when taking Tazorac from the FDA, and is updated regularly.

What is Tazorac?

Tazorac has active ingredients of tazarotene. It is often used in acne. eHealthMe is studying from 1,046 Tazorac users. Check the latest studies of Tazorac.

What is Deep venous thrombosis?

Deep venous thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis) is found to be associated with 2,069 drugs and 2,965 conditions by eHealthMe. Check the latest studies of Deep venous thrombosis.

On Jul, 13, 2026

1,001 people reported to have side effects when taking Tazorac.
Among them, 20 people (2.0%) have Deep venous thrombosis.

Could Tazorac cause Deep venous thrombosis?

Among these 20 people:

How long have people been on Tazorac when they have Deep venous thrombosis? *

What is the gender of people who have Deep venous thrombosis when taking Tazorac? *

female: 60 %
male: 40 %

What is the age of people who have Deep venous thrombosis when taking Tazorac? *

What are other drugs people take besides Tazorac? *

What are other side effects people have besides Deep venous thrombosis? *

Chest Pain: 7 people, 35.00%
Atherosclerosis (disorder of the arteries): 7 people, 35.00%
Heart Attack: 7 people, 35.00%
Diabetes: 7 people, 35.00%
Limb Injury: 7 people, 35.00%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 7 people, 35.00%
Stable Angina (a constant chest pain): 7 people, 35.00%
Cardiac Disorder: 7 people, 35.00%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 6 people, 30.00%
Ventricular Dysfunction (heart dysfunction): 6 people, 30.00%

What are the existing conditions these people have? *

Psoriasis (immune-mediated disease that affects the skin): 7 people, 35.00%
Polycystic Ovary Disease (cysts in the ovaries that occurs when the follicle stops developing): 3 people, 15.00%
Birth Control: 3 people, 15.00%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 10.00%
Post Transplant Lymphoproliferative Disorder: 1 person, 5.00%
Pain: 1 person, 5.00%
Musculoskeletal Discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves): 1 person, 5.00%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 5.00%
Multiple Myeloma (cancer of the plasma cells): 1 person, 5.00%
Fatigue (feeling of tiredness): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Tazorac and have Deep venous thrombosis?

- Check whether Deep venous thrombosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tazorac:

Tazorac (1,046 reports)

Browse all side effects of Tazorac:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Deep venous thrombosis:

Deep venous thrombosis (2,069 drugs)

Browse all the conditions that are associated with Deep venous thrombosis:

Deep venous thrombosis (2,965 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tazarotene (the active ingredients of Tazorac) and Tazorac (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.